Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Center for Cellular Immunotherapies,
Perelman School of Medicine,
Parker Institute for Cancer Immunotherapy,
Center for Cellular Immunotherapies, Perelman School of Medicine
Sangya Agarwal has not added Biography.
If you are Sangya Agarwal and would like to personalize this page please email our Author Liaison for assistance.
Novel prostate cancer immunotherapy with a DNA-encoded anti-prostate-specific membrane antigen monoclonal antibody.
Cancer immunology, immunotherapy : CII Dec, 2017 | Pubmed ID: 28819703
Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge.
Human vaccines & immunotherapeutics 04, 2020 | Pubmed ID: 31799896
Impaired Death Receptor Signaling in Leukemia Causes Antigen-Independent Resistance by Inducing CAR T-cell Dysfunction.
Cancer discovery 04, 2020 | Pubmed ID: 32001516
Harnessing CAR T-cell Insights to Develop Treatments for Hyperinflammatory Responses in Patients with COVID-19.
Cancer discovery 06, 2020 | Pubmed ID: 32303509
LFA-1 signals to promote actin polymerization and upstream migration in T cells.
Journal of cell science Sep, 2020 | Pubmed ID: 32907931
University of Pennsylvania
Sangya Agarwal*,1,2,
Nils Wellhausen*,1,2,
Bruce L. Levine1,2,
Carl H. June1,2
1Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania,
2Parker Institute for Cancer Immunotherapy, University of Pennsylvania
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.